Literature DB >> 10579460

Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro.

Y Ikegishi1, M Tawata, K Aida, T Onaya.   

Abstract

We determined by PCR the number of (A-C)n repeats in the 2. 1 kb upstream of the aldose reductase (AR2) gene in healthy control subjects and in patients with NIDDM in Japanese. Sixty-one patients were recruited based on the severity of retinopathy and subdivided into two groups with proliferative retinopathy and without retinopathy. Japanese exhibited 10 different alleles in this region. The most prevalent allele was designated Z ((A-C)24 repeats) allele. The Z-4 allele was significantly associated with patients with proliferative retinopathy, whereas the Z+2 allele was significantly associated with patients without retinopathy. Erythrocyte AR2 protein levels were significantly elevated in patients exhibiting the Z-4 allele compared to those exhibiting other alleles. When Z-4 allele was ligated in transfection experiments to luciferase vector containing the promoter region of the AR2 gene, the construct showed significantly higher transcription of the reporter gene compared to constructs without (A-C) repeat or with Z-2, Z or Z+2 alleles. Our results suggest that the Z-4 allele in the 2. 1 kb upstream of the AR2 gene may enhance gene transcription and may be a genetic risk factor, which determines the predisposition to retinopathy in Japanese patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579460     DOI: 10.1016/s0024-3205(99)00329-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

2.  Meta-analysis of the association between aldose reductase gene (CA)n microsatellite variants and risk of diabetic retinopathy.

Authors:  Wensheng Mi; Yan Xia; Yanhui Bian
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

3.  Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.

Authors:  Priya Pradhan; Nisha Upadhyay; Archana Tiwari; Lalit P Singh
Journal:  New Front Ophthalmol       Date:  2016-10-24

Review 4.  Human genetics of diabetic retinopathy.

Authors:  Z-H Tang; L Wang; F Zeng; K Zhang
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

Review 5.  Human genetics of diabetic vascular complications.

Authors:  Zi-Hui Tang; Zhou Fang; Linuo Zhou
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

6.  Aldose reductase (AC)n gene polymorphism in Iranian patients with type 2 diabetic microangiopathy; a case-control study.

Authors:  Mohammad Bagher Hashemi-Soteh; Ali Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Amir Ahmadzadeh Amiri; Soleiman Olfat; Ahmad Ahmadzadeh Amiri
Journal:  Diabetol Int       Date:  2020-06-10

Review 7.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

8.  Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy.

Authors:  Flávio Richeti; Renata Maria Noronha; Ricardo Temudo Lessa Waetge; José Paulo Cabral de Vasconcellos; Osías Francisco de Souza; Bianca Kneipp; Nilma Assis; Mylene Neves Rocha; Luís Eduardo Procópio Calliari; Carlos Alberto Longui; Osmar Monte; Monica Barbosa de Melo
Journal:  Mol Vis       Date:  2007-05-23       Impact factor: 2.367

Review 9.  Candidate genes for proliferative diabetic retinopathy.

Authors:  Daniel Petrovič
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

Review 10.  Update on genetics and diabetic retinopathy.

Authors:  Blake M Hampton; Stephen G Schwartz; Milam A Brantley; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.